FDA — authorised 15 July 1999
- Application: NDA021073
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: supplemented
🇺🇸 Actos in United States
FDA authorised Actos on 15 July 1999
Marketing authorisations
FDA
- Status: approved
FDA
- Application: ANDA076799
- Marketing authorisation holder: ALPHAPHARM
- Local brand name: PIOGLITAZONE
- Indication: TABLET — ORAL
- Status: approved
Actos in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Actos approved in United States?
Yes. FDA authorised it on 15 July 1999; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Actos in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.